PRICE FIXING SETTLEMENT

  • glenmark to pay 30mn to settle us price fixing

    Glenmark to pay $30mn to settle US price fixing

    The company was charged with conspiring with generic major Teva to fix prices of the drug. This is the latest resolution in a string of cases related to price fixing, which refers to competitors banding together to artificially set the price of a product in the US market.

Join the community of 2M+ industry professionals

Subscribe to our Daily Newsletter

By continuing you agree to our Privacy Policy & Terms & Conditions

Scan to download App

Download ETHealthworld App for Realtime updates of content you follow

  • Seamless reading experience
  • Save your favourite articles
Advertisement
Advertisement